Nifty

:

24346.70

Sensex

:

80501.99

12.50 (0.05%)
259.75 (0.32%)

Login

Nifty
Sensex

:
:

24346.70
80501.99

12.50 (0.05%)
259.75 (0.32%)

Pfizer Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 500680 | NSE: PFIZER

Watchlist

NSE BSE

4414.95

06-Feb-2025

Open
High
Low
Previous Close

4399.00
4445.95
4370.75
4377.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

26813
1180.12
6451.15
3701.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

19,674.04
31.96
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,395.22
0.81%
5.07

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

1.70
0.38
-5.65

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.29
2.10
-5.34

PAT CAGR (%)

10 Years
5 Years
3 Years

22.95
1.61
-3.45

P:E (Median)

8 Years
5 Years
3 Years

34.84
38.32
34.06

P:BV (Average)

8 Years
5 Years
3 Years

7.07
7.12
6.08

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.90
23.01
21.33

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 120.51 140.24 167.4 182.65
P/E Ratio 44.08 37.88 31.73 29.09
Revenue 2193 2380 2651 2873
EBITDA 636 747 877 939
Net Income 551 646 766 836
ROA 13.4
P/B Ratio 6.76 6.05 5.36 4.77
ROE 16.21 16.85 17.91 17.35
FCFF 366.28 755.8 496.8 541.5
FCFF Yield 1.66 3.42 2.25 2.45

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 537.99 539.97 -0.37% 588.59 575.21 2.33% 562.86 531.36 5.93% 546.63 572.64 -4.54%
Expenses 392.00 387.42 1.18% 399.34 392.60 1.72% 385.37 420.65 -8.39% 357.20 390.77 -8.59%
EBITDA 145.99 152.55 -4.30% 189.25 182.61 3.64% 177.49 110.71 60.32% 189.43 181.87 4.16%
EBIDTM 27.14% 28.25% 32.15% 31.75% 31.53% 20.84% 34.65% 31.76%
Other Income 42.76 35.85 19.27% 43.07 36.07 19.41% 41.84 33.46 25.04% 75.13 31.38 139.42%
Interest 1.51 2.86 -47.20% 2.10 2.73 -23.08% 2.11 2.87 -26.48% 6.95 2.53 174.70%
Depreciation 14.80 17.55 -15.67% 14.99 15.43 -2.85% 14.60 15.55 -6.11% 13.75 26.41 -47.94%
PBT 172.44 175.94 -1.99% 215.23 200.52 7.34% 202.62 125.75 61.13% 243.86 164.72 48.05%
Tax 44.84 45.96 -2.44% 56.88 51.56 10.32% 51.91 32.22 61.11% 65.00 35.07 85.34%
PAT 127.60 129.98 -1.83% 158.35 148.96 6.30% 150.71 93.53 61.14% 178.86 129.65 37.96%
PATM 23.72% 24.07% 26.90% 25.90% 26.78% 17.60% 32.72% 22.64%
EPS 27.92 28.44 -1.83% 34.65 32.60 6.29% 32.98 20.47 61.11% 39.14 28.37 37.96%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,236.07 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65 2,081.50 1,968.51 1,966.26 2,012.34 1,853.32 Net Sales Growth 0.76% -9.55% -7.13% 16.64% 4.04% 3.37% 5.74% 0.11% -2.29% 8.58% Cost Of Goods Sold 797.31 729.77 802.73 875.65 734.29 741.69 678.48 677.55 711.67 698.85 649.77 Gross Profit 1,438.76 1,463.40 1,622.03 1,735.34 1,504.26 1,409.96 1,403.02 1,290.96 1,254.59 1,313.49 1,203.55 GP Margin 64.34% 66.73% 66.89% 66.46% 67.20% 65.53% 67.40% 65.58% 63.81% 65.27% 64.94% Total Expenditure 1,533.91 1,557.85 1,615.81 1,775.05 1,526.15 1,578.93 1,515.87 1,467.87 1,616.13 1,579.46 1,473.98 Power & Fuel Cost - 3.98 6.51 5.67 5.79 11.04 11.45 12.34 10.34 10.43 10.40 % Of Sales - 0.18% 0.27% 0.22% 0.26% 0.51% 0.55% 0.63% 0.53% 0.52% 0.56% Employee Cost - 347.80 331.68 403.67 361.06 364.51 323.84 314.29 303.89 277.34 236.36 % Of Sales - 15.86% 13.68% 15.46% 16.13% 16.94% 15.56% 15.97% 15.46% 13.78% 12.75% Manufacturing Exp. - 113.97 122.57 132.19 123.71 104.97 131.96 118.74 151.54 153.84 162.31 % Of Sales - 5.20% 5.05% 5.06% 5.53% 4.88% 6.34% 6.03% 7.71% 7.64% 8.76% General & Admin Exp. - 158.53 158.87 162.66 130.80 165.96 182.49 173.38 234.11 207.63 202.62 % Of Sales - 7.23% 6.55% 6.23% 5.84% 7.71% 8.77% 8.81% 11.91% 10.32% 10.93% Selling & Distn. Exp. - 159.43 139.16 148.11 137.87 153.70 152.83 143.35 152.82 168.00 156.82 % Of Sales - 7.27% 5.74% 5.67% 6.16% 7.14% 7.34% 7.28% 7.77% 8.35% 8.46% Miscellaneous Exp. - 44.37 54.29 47.10 32.63 37.06 34.82 28.22 51.76 63.38 156.82 % Of Sales - 2.02% 2.24% 1.80% 1.46% 1.72% 1.67% 1.43% 2.63% 3.15% 3.01% EBITDA 702.16 635.32 808.95 835.94 712.40 572.72 565.63 500.64 350.13 432.88 379.34 EBITDA Margin 31.40% 28.97% 33.36% 32.02% 31.82% 26.62% 27.17% 25.43% 17.81% 21.51% 20.47% Other Income 202.80 180.51 101.05 62.65 81.12 184.02 167.39 114.29 101.16 86.99 71.72 Interest 12.67 15.43 13.48 10.70 15.39 11.01 1.72 0.77 1.96 1.40 1.51 Depreciation 58.14 62.28 105.51 115.00 109.41 103.24 71.39 66.25 62.93 57.93 131.08 PBT 834.15 738.12 791.01 772.89 668.72 642.49 659.91 547.91 386.40 460.54 318.46 Tax 218.63 194.74 200.08 160.33 171.11 133.36 230.86 187.84 180.05 165.44 137.68 Tax Rate 26.21% 26.10% 24.28% 20.74% 25.59% 20.76% 34.98% 34.28% 34.84% 35.17% 66.36% PAT 615.52 551.33 623.93 612.56 497.61 509.13 429.05 360.07 336.78 304.98 69.82 PAT before Minority Interest 615.52 551.33 623.93 612.56 497.61 509.13 429.05 360.07 336.78 304.98 69.82 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 27.53% 25.14% 25.73% 23.46% 22.23% 23.66% 20.61% 18.29% 17.13% 15.16% 3.77% PAT Growth 22.58% -11.64% 1.86% 23.10% -2.26% 18.66% 19.16% 6.92% 10.43% 336.81% EPS 134.69 120.64 136.53 134.04 108.89 111.41 93.88 78.79 73.69 66.74 15.28

Description TTM Nov 08 Nov 07 Nov 06 Nov 05
Net Sales - 736.83 736.57 736.33 674.84 Net Sales Growth - 0.04% 0.03% 9.11% Cost Of Goods Sold - 195.94 190.88 186.99 189.67 Gross Profit - 540.89 545.69 549.34 485.17 GP Margin - 73.41% 74.09% 74.61% 71.89% Total Expenditure - 585.58 580.08 570.64 558.84 Power & Fuel Cost - 7.17 7.94 7.50 7.96 % Of Sales - 0.97% 1.08% 1.02% 1.18% Employee Cost - 98.43 98.71 100.37 98.57 % Of Sales - 13.36% 13.40% 13.63% 14.61% Manufacturing Exp. - 92.14 85.84 85.45 80.87 % Of Sales - 12.50% 11.65% 11.60% 11.98% General & Admin Exp. - 49.05 48.30 45.81 45.04 % Of Sales - 6.66% 6.56% 6.22% 6.67% Selling & Distn. Exp. - 99.87 106.89 103.95 96.59 % Of Sales - 13.55% 14.51% 14.12% 14.31% Miscellaneous Exp. - 42.98 41.51 40.57 40.15 % Of Sales - 5.83% 5.64% 5.51% 5.95% EBITDA - 151.25 156.49 165.69 116.00 EBITDA Margin - 20.53% 21.25% 22.50% 17.19% Other Income - 71.10 321.80 33.47 33.24 Interest - 0.00 0.02 0.07 0.16 Depreciation - 11.12 9.58 13.07 13.85 PBT - 211.22 468.69 186.01 135.23 Tax - 119.56 111.34 56.31 41.13 Tax Rate - 28.53% 24.67% 34.62% 36.77% PAT - 299.57 340.00 106.33 70.73 PAT before Minority Interest - 299.57 340.00 106.33 70.73 Minority Interest - 0.00 0.00 0.00 0.00 PAT Margin - 40.66% 46.16% 14.44% 10.48% PAT Growth - -11.89% 219.76% 50.33% EPS - 65.55 74.40 23.27 15.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,595.54 3,207.30 2,864.41 2,393.04 3,395.49 3,011.34 2,683.20 2,418.88 2,163.50 1,973.01 Share Capital 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 Total Reserves 3,549.79 3,161.55 2,818.66 2,347.29 3,349.74 2,965.59 2,637.45 2,373.13 2,117.75 1,927.26 Non-Current Liabilities 32.74 38.41 136.23 85.06 135.93 36.96 52.32 62.41 66.14 -34.97 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.50 2.50 Long Term Provisions 32.33 42.76 55.47 55.84 47.87 34.73 37.74 44.85 35.30 29.56 Current Liabilities 546.56 657.35 852.89 774.34 873.36 891.69 954.44 779.67 658.41 608.52 Trade Payables 166.23 217.06 263.94 283.74 426.78 435.92 495.63 388.00 337.92 334.20 Other Current Liabilities 172.80 176.49 345.92 361.47 340.37 294.19 302.29 241.36 181.52 80.59 Short Term Borrowings 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 0.00 0.00 Short Term Provisions 205.03 261.30 240.53 126.63 103.71 159.08 154.02 147.81 138.97 193.72 Total Liabilities 4,174.84 3,903.06 3,853.53 3,252.44 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 2,546.56 Net Block 712.71 749.25 840.96 864.74 941.91 853.86 916.60 867.08 924.86 944.34 Gross Block 1,355.73 1,352.40 1,345.28 1,278.52 1,277.00 1,100.27 1,094.86 983.27 980.63 1,288.60 Accumulated Depreciation 643.02 603.15 504.32 413.78 335.09 246.41 178.26 116.19 55.77 344.26 Non Current Assets 1,405.28 1,377.97 1,457.05 1,343.96 1,356.53 1,224.63 1,273.24 1,209.65 1,255.58 1,294.53 Capital Work in Progress 0.40 7.93 1.15 2.76 0.76 0.00 1.04 15.35 3.27 12.56 Non Current Investment 0.00 0.00 0.00 29.56 30.95 32.33 33.72 35.11 36.51 42.66 Long Term Loans & Adv. 589.78 550.26 549.20 291.62 255.26 225.11 236.25 226.29 225.71 294.97 Other Non Current Assets 102.39 70.53 37.57 155.28 127.65 113.33 85.63 65.82 65.23 0.00 Current Assets 2,737.81 2,493.34 2,361.44 1,908.48 3,048.25 2,715.36 2,416.72 2,051.31 1,632.47 1,252.02 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 433.69 417.70 448.90 435.05 430.59 386.66 297.06 321.90 360.68 387.90 Sundry Debtors 187.61 151.73 142.55 108.77 172.03 171.66 154.80 110.32 142.30 160.02 Cash & Bank 2,046.71 1,859.52 1,643.44 1,115.10 2,219.87 1,914.34 1,771.86 1,523.09 1,024.65 609.29 Other Current Assets 69.80 21.79 23.02 231.13 225.76 242.70 193.00 96.00 104.85 94.82 Short Term Loans & Adv. 48.49 42.60 103.53 18.43 25.82 29.80 45.96 52.48 57.20 80.52 Net Current Assets 2,191.25 1,835.99 1,508.55 1,134.14 2,174.89 1,823.67 1,462.28 1,271.64 974.06 643.51 Total Assets 4,143.09 3,871.31 3,818.49 3,252.44 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 2,546.55

Description Nov 08 Nov 07 Nov 06 Nov 05
Shareholder's Funds 901.09 649.72 439.76 375.95 Share Capital 29.84 29.84 29.84 29.84 Total Reserves 871.25 619.88 409.91 346.11 Non-Current Liabilities -22.67 -12.98 -14.36 -9.03 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 Current Liabilities 926.36 820.65 696.33 623.95 Trade Payables 108.18 92.43 137.62 120.16 Other Current Liabilities 14.50 14.17 8.14 16.26 Short Term Borrowings 0.00 0.00 0.00 0.00 Short Term Provisions 803.68 714.05 550.57 487.53 Total Liabilities 1,804.78 1,457.39 1,121.73 990.87 Net Block 50.76 60.16 69.96 75.56 Gross Block 139.90 141.61 168.14 170.15 Accumulated Depreciation 89.14 81.45 98.19 94.59 Non Current Assets 83.56 70.91 71.56 77.71 Capital Work in Progress 32.30 10.24 1.60 2.14 Non Current Investment 0.50 0.50 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 1,721.22 1,383.55 1,036.82 876.46 Current Investments 0.00 0.00 0.00 0.00 Inventories 124.99 95.85 99.31 90.71 Sundry Debtors 60.31 61.69 70.10 83.54 Cash & Bank 543.65 479.91 306.94 210.15 Other Current Assets 992.26 8.17 4.22 2.14 Short Term Loans & Adv. 977.77 737.92 556.25 489.92 Net Current Assets 794.86 562.90 340.50 252.52 Total Assets 1,804.78 1,457.39 1,121.72 990.87

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 256.84 355.68 667.08 427.33 323.18 97.81 331.80 328.82 345.48 113.47 PBT 746.07 824.01 772.89 668.72 642.49 659.91 547.91 516.83 470.42 238.02 Adjustment -89.32 -131.26 76.17 54.53 -53.56 -79.47 -32.98 -153.93 -19.53 60.89 Changes in Working Capital -246.09 -34.49 43.94 -91.78 -52.46 -245.07 10.48 148.91 68.61 -40.42 Cash after chg. in Working capital 410.66 658.26 893.00 631.47 536.47 335.37 525.41 511.81 519.51 258.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -153.82 -302.58 -225.92 -204.14 -213.29 -237.56 -193.61 -182.99 -174.03 -145.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 53.70 -36.05 -575.02 -468.84 1,530.32 35.12 -238.31 -249.64 -700.87 -88.77 Net Fixed Assets 4.20 -13.90 -65.15 -3.52 -177.49 -4.37 -97.28 -14.72 317.26 -1,183.17 Net Investments 0.00 0.00 29.56 1.39 1.38 1.39 1.39 1.40 6.15 1.83 Others 49.50 -22.15 -539.43 -466.71 1,706.43 38.10 -142.42 -236.32 -1,024.28 1,092.57 Cash from Financing Activity -235.14 -345.79 -180.51 -1,571.07 -163.52 -109.85 -110.35 -82.59 -61.88 -1.38 Net Cash Inflow / Outflow 75.40 -26.16 -88.45 -1,612.58 1,689.98 23.08 -16.86 -3.41 -417.27 23.32 Opening Cash & Equivalents 36.60 62.76 151.21 1,763.79 73.81 50.73 67.59 71.05 488.40 307.86 Closing Cash & Equivalent 112.00 36.60 62.76 151.21 1,763.79 73.81 50.73 67.59 71.05 488.40

Description Nov 08 Nov 07 Nov 06 Nov 05
Cash From Operating Activity 237.76 16.63 123.19 102.74 PBT 211.22 468.69 186.01 135.23 Adjustment -49.50 -298.40 -8.73 7.24 Changes in Working Capital -7.89 -33.39 11.64 -2.41 Cash after chg. in Working capital 153.83 136.91 188.92 140.06 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -126.90 -113.33 -65.74 -37.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -78.87 232.35 -47.99 -73.08 Net Fixed Assets -20.35 17.89 2.55 Net Investments 0.00 -0.50 0.00 Others -58.52 214.96 -50.54 Cash from Financing Activity -95.20 -75.90 -33.82 -46.02 Net Cash Inflow / Outflow 63.69 173.09 41.38 -16.36 Opening Cash & Equivalents 479.91 306.83 10.00 26.36 Closing Cash & Equivalent 543.61 479.91 51.38 10.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 785.91 701.05 626.10 523.07 742.18 658.22 586.49 528.72 472.92 431.28 ROA 13.65% 16.09% 17.24% 13.00% 12.20% 11.25% 10.36% 10.95% 11.22% 4.00% ROE 16.21% 20.55% 23.30% 17.19% 15.89% 15.07% 14.11% 14.70% 14.75% 5.31% ROCE 22.37% 27.56% 29.78% 23.62% 20.38% 23.22% 21.49% 22.62% 22.78% 15.87% Fixed Asset Turnover 1.71 1.90 2.07 1.75 1.81 1.90 1.91 2.08 1.85 2.75 Receivable days 26.74 20.98 16.89 22.89 29.15 28.62 24.43 22.58 26.35 31.59 Inventory Days 67.09 61.77 59.41 70.57 69.32 59.95 57.05 61.01 65.25 51.10 Payable days 95.85 109.36 114.15 176.59 102.95 115.62 121.93 93.70 92.76 62.95 Cash Conversion Cycle -2.02 -26.61 -37.84 -83.13 -4.48 -27.05 -40.45 -10.12 -1.16 19.73 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 49.35 62.13 73.23 44.45 59.36 384.67 712.57 264.69 337.93 138.46

Description Nov 08 Nov 07 Nov 06 Nov 05
Book Value (Rs.) 301.96 216.74 142.90 113.68 ROA 18.37% 26.37% 10.07% 9.39% ROE 38.71% 63.36% 27.78% 22.90% ROCE 54.15% 84.11% 42.50% 35.52% Fixed Asset Turnover 5.62 5.16 4.71 4.43 Receivable days 28.15 30.12 35.19 39.05 Inventory Days 50.96 44.60 43.53 41.49 Payable days 69.16 84.39 92.33 80.44 Cash Conversion Cycle 9.95 -9.68 -13.61 0.09 Total Debt/Equity 0.00 0.00 0.00 0.00 Interest Cover 0.00 0.00 2275.76 712.58

Top Investors:

nippon life india trustee ltd

life insurance corporation of india

quant mutual fund

sbi mutual fund

icici prudential mutual fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Pfizer gets nod to enter into Marketing and Supply Agreement with Mylan Pharmaceuticals
21st Feb 2025, 15:44 PM

The said Marketing and supply agreement will be for a period of 5 years within the territory of India
Read More
Pfizer - Quarterly Results
31st Jan 2025, 17:04 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback